These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7464555)

  • 21. Lecithin: cholesterol acyltransferase activity in familial hypercholesterolemia treated with simvastatin and simvastatin plus low-dose colestipol.
    Desager JP; Horsmans Y; Harvengt C
    J Clin Pharmacol; 1991 Jun; 31(6):537-42. PubMed ID: 1880219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of fenofibrate on insulin sensitivity and plasma lipid profile in non-diabetic males with low high density lipoprotein/dyslipidaemic syndrome.
    Yong QW; Thavintharan S; Cheng A; Chew LS
    Ann Acad Med Singap; 1999 Nov; 28(6):778-82. PubMed ID: 10672386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial rate of cholesterol esterification association with high density lipoproteins in human plasma.
    Pinon JC; Bridoux AM; Laudat MH
    J Lipid Res; 1980 May; 21(4):406-14. PubMed ID: 7381332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.
    Yen FT; Deckelbaum RJ; Mann CJ; Marcel YL; Milne RW; Tall AR
    J Clin Invest; 1989 Jun; 83(6):2018-24. PubMed ID: 2723070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between plasma levels of fenofibrate and lipoprotein changes in hyperlipidaemic patients.
    Sirtori CR; Montanari G; Gianfranceschi G; Sirtori M; Galli G; Bosisio E
    Eur J Clin Pharmacol; 1985; 28(6):619-24. PubMed ID: 3840743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.
    Genest J; Nguyen NH; Theroux P; Davignon J; Cohn JS
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):164-72. PubMed ID: 10630748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of pharmacokinetic interaction of colestipol and fenofibrate in volunteers.
    Harvengt C; Desager JP
    Eur J Clin Pharmacol; 1980 Jun; 17(6):459-63. PubMed ID: 7398737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
    Crouse JR; Grundy SM
    Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of high density lipoproteins in lecithin:cholesterol acyltransferase activity: perspectives from Tangier disease.
    Assmann G; Schmitz G; Heckers H
    Scand J Clin Lab Invest Suppl; 1978; 150():98-102. PubMed ID: 218282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein metabolism in postmenopausal and oophorectomized women.
    Wakatsuki A; Sagara Y
    Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
    Rose HG; Haft GK; Juliano J
    Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects.
    Shepherd J; Caslake MJ; Lorimer AR; Vallance BD; Packard CJ
    Arteriosclerosis; 1985; 5(2):162-8. PubMed ID: 3977776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma HDL cholesterol and the in vitro esterification of cholesterol.
    Stokke KT; Enger SC
    Scand J Clin Lab Invest; 1979 Nov; 39(7):597-600. PubMed ID: 231292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
    Hoogwerf BJ; Peters JR; Frantz ID; Hunninghake DB
    Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidemic obese patients.
    Coban E; Sari R
    Endocr Res; 2004 Aug; 30(3):343-9. PubMed ID: 15554350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia.
    Malmendier CL; Delcroix C
    Atherosclerosis; 1985 May; 55(2):161-9. PubMed ID: 3924068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences among hyperlipoproteinaemic subjects in the response of lipoprotein lipids to resin therapy.
    Miller NE; Nestel PJ
    Eur J Clin Invest; 1975 Jun; 5(3):241-7. PubMed ID: 1149783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of smoking on serum lipid and lipoprotein concentrations and lecithin: cholesterol acyltransferase activity.
    Dirican M; Sarandöl E; Ulukaya E; Tokullugil HA
    J Med Invest; 1999 Aug; 46(3-4):169-72. PubMed ID: 10687311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
    Vega GL; Ma PT; Cater NB; Filipchuk N; Meguro S; Garcia-Garcia AB; Grundy SM
    Am J Cardiol; 2003 Apr; 91(8):956-60. PubMed ID: 12686335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.